Dystrophine Calcium handling Emery-Dreifuss muscular dystrophy Base de données FAIR Muscular dystrophy MD Angiotensin-converting enzyme inhibitor Myopathies Butyrylcholinesterase LMNA Biological sciences Maladies rares et orphelines Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Ehlers‐Danlos Syndrome CMTX Therapy Autophagosome maturation Myotubes Allele-specific silencing therapy Clinical trial GNE IPSC Joint laxity COL6A1 Regeneration A-type lamins Allele-specific silencing Mouse RNA interference Dystrophie musculaire Muscle biopsy A-type lamin Nuclear envelope Cardiomyopathy Patient registry BiP Rare diseases Lamin A/C LMNA gene Congenital muscular dystrophy Exome Diagnosis Becker muscular dystrophy AAV VECTOR Titin COVID-19 Gene therapy COL1A1 Muscle MRI Hypermobile EDS LMNA gene C2C12 Angiotensin-converting enzyme inhibitors POPDC1 Laminopathy Skeletal muscle Muscular dystrophy CRISPR Centronuclear myopathy Allele‐specific silencing therapy Cancer biomarkers INPP5K Actionable gene Lamin A/C nuclei COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Cardiology Cardiac conduction system LGMD Adult SMA Next generation sequencing Alternative splicing Myologie BVES Cancer Heart failure Errance diagnostique Muscle Rare neuromuscular diseases Lamin A/C Myopathy Acetyltransferase Emerin LMNA-related congenital muscular dystrophy AAV Laminopathies Connective tissue Laminopathie Lamins Neuromuscular diseases Actionability Maladies rares Treatment Myogenesis Biomarker Dilated cardiomyopathy Heart Mutations CSF protein Dynamin 2 C elegans Treatment delay Duchenne muscular dystrophy